GILLA KAPLAN
CIK 1247024 · last filed 2026-06-04
GILLA KAPLAN is a corporate insider who has filed 75 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for AVTX, was dated Jun 4, 2026. Across all open-market trades the lifetime net is −$44.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.19M
5
75
-$44.27M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVTX | Director | 3,167 | $14.76 | $46.7K | $0 | 11 | 2026-06-04 |
| TYRA | Director | 42,526 | $26.99 | $1.15M | -$1.16M | 8 | 2026-03-27 |
| Avalo Therapeutics, Inc. (CERC) Delisted | Director | — | $2.93 | — | $0 | 5 | 2021-07-02 |
| CELGENE CORP /DE/ (CELGZ) Delisted | Director | 121,837 | — | — | -$36.57M | 39 | 2018-05-21 |
| CELGENE CORP /DE/ (CELG) Delisted | Director | 685 | — | — | -$6.54M | 12 | 2010-06-18 |
Recent Filings
75 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-04 | AVTX | Grant (A) | — | $0 | EDGAR |
| 2026-03-27 | TYRA | Mixed | −106,344 | -$2.62M | EDGAR |
| 2025-06-20 | TYRA | Sell (S) | −9,578 | -$93.7K | EDGAR |
| 2025-06-18 | AVTX | Grant (A) | — | $0 | EDGAR |
| 2025-06-16 | TYRA | Sell (S) | −51,814 | -$534.6K | EDGAR |
| 2025-06-02 | TYRA | Grant (A) | — | $0 | EDGAR |
| 2025-04-01 | AVTX | Exer (M) | +3,167 | $0 | EDGAR |
| 2024-08-14 | AVTX | Grant (A) | — | $0 | EDGAR |
| 2024-06-18 | TYRA | Exer (M) | +61,392 | $37.4K | EDGAR |
| 2024-05-31 | TYRA | Grant (A) | — | $0 | EDGAR |